What is vaginal metronidazole used for? Vaginal metronidazole is an antibiotic that is commonly used for an infection called bacterial vaginosis that is caused by certain bacteria. Vaginal ...

Metronidazole 0.75%; vaginal gel; contains parabens. Discontinue if abnormal neurological signs develop. CNS or hepatic disease. Abstain from vaginal intercourse during therapy. Pregnancy (Cat.B).

although secondary vaginal candidiasis occurred significantly more often in metronidazole-treated women. Metronidazole 500 mg orally twice daily for 7 days, or Metronidazole gel (0.75%), one full ...

The drug is available in several forms: immediate-release oral tablets and capsules extended-release oral tablets topical creams, gels, and lotions vaginal gels The different forms of ...

Metronidazole vaginal gel 0.75% to launch immediately -- BRIDGEWATER, N.J., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Solaris Pharma Corporation (“Solaris”) announced today that the U.S. Food and Drug ...

There have not been any studies looking at the cancer risk of metronidazole vaginal gel. People may receive a prescription and purchase metronidazole gel from Nurx, an online pharmacy. The cost ...

The generic name of the gel is Metronidazole Vaginal Gel. "Metronidazole vaginal gel is a widely used antibacterial preparation, and its generic version can bring significant savings to the ...

Actavis and Valeant announced that the FDA has approved Metronidazole 1.3% Vaginal Gel for the treatment of bacterial vaginosis. In April 2013, Actavis acquired the rights to Metronidazole 1.3% ...

Metronidazole comes in several forms. These include an oral tablet, an oral capsule, a cream, gel, and lotion you apply to your skin, and a vaginal gel. It also comes as an injectable medication ...

Seven-day course of treatment�250 mg three times daily for seven consecutive days. Vaginal Gel- one applicator is administered intravaginally once a day for 5 days.

DUBLIN and LAVAL, Quebec — Actavis and Valeant Pharmaceuticals International announced that the Food and Drug Administration approved the new drug application for Metronidazole 1.3% vaginal gel.